David Eichler

Dave is Co-Founder and Managing Partner of Valeo Ventures. He currently serves on the Board of Directors of AristaMD, Nymbl Science and PayForward and is a Board Observer for Scipher Medicine and Second Wave Delivery Systems.

Dave has over 28 years of experience working with healthcare leaders and entrepreneurs as a venture capital investor, board member and strategic advisor. Prior to Valeo, he was President and Managing Partner of Cobalt Ventures leading an investment team focused on companies that improve access, affordability and quality of care for healthcare consumers. Dave was also a founding Partner at Cleveland Clinic Ventures where he collaborated with key enterprise stakeholders on strategic investments, spinouts and joint ventures supporting digital health innovation at the #2 ranked hospital in the world. From 1999-2017, Dave was a founding member and Managing Partner of Psilos Group, a leading healthcare venture capital firm with approximately $600 million under management.

In addition to his investing roles, Dave’s background includes various senior operating roles at Caregiver Services, Inc. (a Psilos portfolio company) during periods of transformational growth at the company. Earlier in his career, Dave was an investment banker at Wasserstein Perella & Co. as a member of the firm’s Healthcare Group. Dave earned an MBA from the Darden School of Business at the University of Virginia. He holds another master’s degree in National Security Studies from Georgetown University and a B.A. in Government and International Relations from Cornell University, where he graduated magna cum laude.

As empty nesters with two adult children, Dave and his wife are now raising the most stubborn dog on the planet (a 3-year old Great Pyrenees named Brewer), while splitting time between Kansas City and Maine.